
From Reactive to Proactive: Evolving Health Systems for CRM Management
How combined therapies and proactive, team-based CRM care cut costs, streamline meds, and improve heart, kidney, and metabolic outcomes.
Episodes in this series

In ‘From Reactive to Proactive: Evolving Health Systems for CRM Management,’ the expert cardiologist examined the following critical questions:
What is the future potential for therapies with combined mechanisms of action?
How can health systems move from reactive to proactive CRM care models and what is the role of population health efforts in this?
How can multidisciplinary collaboration improve care coordination across the CRM continuum?
The panelist discussed the shifting landscape of cardio-renal-metabolic (CRM) care, emphasizing the potential for therapies with combined mechanisms of action to improve patient adherence and clinical efficiency. Ian Neeland explained that health systems must transition from reactive treatment to proactive, population-based models that utilize staging to identify high-risk patients before complications arise. By breaking down clinical silos and implementing multidisciplinary teams—such as the Cinema program model—providers can ensure integrated coordination that addresses the complex confluence of type 2 diabetes, obesity, and chronic kidney disease. This collaborative approach is essential for reducing hospitalizations and improving long-term cardiovascular outcomes through the delivery of synchronized, evidence-based care.
Throughout the conversation, the expert provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.
In the next episode, ‘Investing in the Future: Redesigning Healthcare Infrastructure for CRM Excellence’, the panelist will continue their discussion on cardio-renal-metabolic (CRM) syndrome and highlight methods to align care teams around patient-centered goals and strategies for creating a culture of shared responsibility.




